|
Lucio Tentori, Carlo
Leonetti, Marco Scarsella, Giulia d'Amati, Weizheng Xu, Vincent
Kalish, Jie Zhang, Gabriella Zupi, Grazia Graziani
Systemic administration of the PARP
inhibitor GPI 15427 increases the anti-tumor activity of
temozolomide in melanoma, glioma and lymphoma preclinical models
in vivo
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract
No. 5466 (Animal Study)
|
